Management of male pattern baldness

Study of efficacy of finasteride and minoxidil versus finasteride and minoxidil with dermaroller in male pattern baldness

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/10/010156

Enrollment

Registered

2017-10-23

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Male Pattern Baldness

Interventions

Intervention1: 10% topical minoxidil tablet finasteride 1 mg microneedling: all the above 3 treatment modalities have been used in combination to see the faster result in the form of hair growth at th

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age between 20 to 35 yrs 2.Male pattern baldness 3.Not any history of oral medication or topical medication for hair loss for the past 3 months

Exclusion criteria

Exclusion criteria: 1. Age less then 20 yrs and more than 35 yrs 2. patient not on any treatment for hair loss for the past 3 months 3. known allergy to minoxidil or finasteride , bleeding disorder, hypersensitivity, keloidal tendency.

Design outcomes

Primary

Measure	Time frame
combination therapy shows moderate to excellent response on physician assessment scaleTimepoint: 6 months	—

Secondary

Measure	Time frame
combination therapy shows moderate to excellent response on physician assessment scaleTimepoint: at the end of 6 months	—

Countries

India

Contacts

Public ContactDr Sanjiv Choudhary

Jawahar lal Nehru Medical College

sanjiv_choudhary26@yahoo.com9823165012

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026